Recent Finacing
Recent Raise
TenNor Therapeutics is a Suzhou-based clinical-stage biopharma developing multi-targeting/dual-acting antibiotic conjugates (e.g., TNP-2092/rifasutenizol) for H. pylori, gastrointestinal, and device infections.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
